Christina Drenberg Guttke
Research Assistant Professor
Pharmaceutics and Pharmaceutical Chemistry
404 Biomedical Research Tower


  • Preclinical development of novel treatment strategies for pediatric acute myeloid leukemia
  • Translational pharmacology of anti-cancer therapeutics
  • Contribution of pharmacogenomics to inter- and intra-patient variability

Professional Interests

Dr. Drenberg-Guttke’s cancer-relevant research interests broadly cover translational and pre-clinical pharmacology of anti-cancer therapeutics. Her laboratory is focused on addressing an unmet need to identify effective treatment strategies for children with acute myeloid leukemia (AML).  Dr. Drenberg-Guttke’s research interests include integration of genomic expression data with high-throughput drug screening methods and utilization of multiple preclinical models to interrogate novel drug combinations.


  • April 2016 – present:  Career Development Committee Member, American Society for Clinical Pharmacology and Therapeutics
  • April 2016 : American Association for Cancer Research Women in Cancer Research Scholar Award
  • March 2016: American Society for Clinical Pharmacology and Therapeutics Presidential Trainee Award
  • April 2015: American Association for Cancer Research – June Biedler Scholar-in-Training Award: recognizing meritorious proffered papers in the field of drug resistance


  • Postdoctoral Fellow – 2015-2016 – The Ohio State University, College of Pharmacy, Division of Pharmaceutics
  • Postdoctoral Research Associate – 2011-2015 St. Jude Children’s Research Hospital
  • PhD – 2010 University of South Florida, College of Medicine, Medical Sciences
  • BS – 2005 University of South Florida, Biomedical Sciences

Recent Publications